Evidence map›Paper›PMID 35487478›Full record

ArticleDiabetes & metabolism2022

Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes.

Serena Pezzilli, Manoush Tohidirad, Tommaso Biagini, Maria Giovanna Scarale, Federica Alberico, Luana Mercuri, Gaia Chiara Mannino, Monia Garofolo, Tiziana Filardi, Yaling Tang and 21 more

Abstract read
In one paragraph

Article in Diabetes & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 11 institutions in 2 countries.

Serena PezzilliResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Manoush TohidiradResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Tommaso BiaginiUnit of Bioinformatics, Fondazione IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Maria Giovanna ScaraleResearch Unit of Diabetes and Endocrine Diseases, Fondazione IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Federica AlbericoResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Luana MercuriResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Gaia Chiara ManninoDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Monia GarofoloSection of Diabetes and Metabolic Disease, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Tiziana FilardiDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Yaling TangResearch Division, Joslin Diabetes Center, Boston, MA, United States; Department of Medicine, Harvard Medical School, Boston, MA United States.
Fernando GiuffridaResearch Division, Joslin Diabetes Center, Boston, MA, United States.
Christine MendoncaResearch Division, Joslin Diabetes Center, Boston, MA, United States.
Francesco AndreozziDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy; Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS), University Magna Grecia, Catanzaro, Italy.
Marco Giorgio BaroniDepartment of Clinical Medicine, Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy; Neuroendocrinology and Metabolic Diseases, IRCCS Neuromed, Pozzilli, Italy.
Raffaella BuzzettiDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Maria Gisella CavalloDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Efisio CossuDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Paola D'AngeloUnit of Diabetology, Sandro Pertini Hospital, Rome, Italy.
Salvatore De CosmoDepartment of Medicine, Fondazione IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Olga LamacchiaUnit of Endocrinology, Department of Medical and Surgical Sciences, University Hospital of Foggia, Foggia, Italy.
Frida LeonettiDiabetes Unit, Department of Medical-Surgical Sciences and Biotechnologies, Santa Maria Goretti Hospital, Sapienza University of Rome, Latina, Italy.
Susanna MoranoDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Lelio MorviducciUnit of Diabetology, S. Spirito Hospital - AslRM1, Rome, Italy.
Giuseppe PennoDepartment of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Paolo PozzilliDepartment of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Rome, Italy.
Giuseppe PuglieseDepartment of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Giorgio SestiDepartment of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Tommaso MazzaUnit of Bioinformatics, Fondazione IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Alessandro DoriaResearch Division, Joslin Diabetes Center, Boston, MA, United States; Department of Medicine, Harvard Medical School, Boston, MA United States.
Vincenzo TrischittaResearch Unit of Diabetes and Endocrine Diseases, Fondazione IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Department of Experimental Medicine, Sapienza University, Rome, Italy.
Sabrina PrudenteResearch Unit of Metabolic and Cardiovascular Diseases, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. Electronic address: s.prudente@css-mendel.it.
Casa Sollievo della Sofferenza · ITJoslin Diabetes Center · USSapienza University of Rome · ITMagna Graecia University · ITUniversity of L'Aquila · ITOspedale di Santo Spirito · ITOspedale Sandro Pertini · ITUniversità Campus Bio-Medico · ITUniversity of Cagliari · ITUniversity of Foggia · ITUniversity of Pisa · IT

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

aimThis study investigated whether rare, deleterious variants in monogenic diabetes-genes are associated with early-onset type 2 diabetes (T2D).

methodsA nested case-control study was designed from 9712 Italian patients with T2D. Individuals with age at diabetes onset ≤35 yrs (n = 300; cases) or ≥65 yrs (n = 300; controls) were selected and screened for variants in 27 monogenic diabetes-genes by targeted resequencing. Rare (minor allele frequency-MAF <1%) and possibly deleterious variants were collectively tested for association with early-onset T2D. The association of a genetic risk score (GRS) based on 17 GWAS-SNPs for T2D was also tested.

resultsWhen all rare variants were considered together, each increased the risk of early-onset T2D by 65% (allelic OR =1.64, 95% CI: 1.08-2.48, p = 0.02). Effects were similar when the 600 study participants were stratified according to their place of recruitment (Central-Southern Italy, 182 cases vs. 142 controls, or Rome urban area, 118 vs. 158, p for heterogeneity=0.53). Progressively less frequent variants showed increasingly stronger effects in the risk of early-onset T2D for those with MAF <0.001% (OR=6.34, 95% CI: 1.87-22.43, p = 0.003). One unit of T2D-GRS significantly increased the risk of early-onset T2D (OR 1.09, 95% CI: 1.01-1.18; p = 0.02). This association was stronger among rare variants carriers as compared to non-carriers (p = 0.02).

conclusionRare variants in monogenic-diabetes genes are associated with an increased risk of early-onset T2D, and interact with common T2D susceptibility variants in shaping it. These findings might help develop prediction tools to identify individuals at high risk of developing T2D in early adulthood.

Indexed as

Diabetes Mellitus, Type 2AdultCase-Control StudiesGene FrequencyGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideEarly-onset type 2 diabetesMonogenic diabetes, genetic risk scoreRare variantsType 2 diabetes

Identifiers

PMID35487478
PMCPMC12635831
OpenAlexW4224884867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.